Dollar_D Posted - 12 minutes ago

$ALRN y it is keep on dropping after reporting positive data ?

Stocksrockman Posted - 4 days ago

$ALRN $POLA $PROC $ZONE Zone 1.9 mil float bottom play

RealErnFranklin Posted - 4 days ago

$ALRN souble bottom 1.7 $PROC hearing thats a buy and hold $pola new float soon 1.7m $zone is 1.9m float , active in pump already. Take advantage, get what u can gotta play it to gain 🏦

Onatarty Posted - 1 week ago

$CMRX $ALRN 🚨💥🚀🔥 PR is incoming. $BOLT.CN $.31 (+19.23%) average volume increased ~100%. I'm going to add on Monday if it's still this low. Latest News 🚀🤑 Market cap at $5.7M; Whiting’s influence may drive upward movement if new partnerships or exploration progress 1️⃣ Bolt Metals ($BOLT.CN) advances with two key updates: Ben Whiting joins as Technical Advisor, and a C$544,500 private placement closed 💸. 2️⃣ Funding: The placement includes shares and warrants, exercisable at C$0.75 for two years, with proceeds for exploration, working capital, and copper project growth ⚒️

OpenOutcrier Posted - 1 week ago

$ALRN (+5.5% pre) Aileron reports promising phase 1b trial results for IPF treatment - inv https://ooc.bz/l/47912

DonCorleone77 Posted - 1 week ago

$ALRN Aileron reports results from Cohort 2 of its Phase 1b clinical trial of LTI-03 Aileron Therapeutics announced positive topline data from Cohort 2 of its Phase 1b clinical trial evaluating the safety and tolerability of inhaled LTI-03 in patients diagnosed with idiopathic pulmonary fibrosis, or IPF. LTI-03 is a novel, Caveolin-1-related peptide that modulates both pro-fibrotic activity and sustain critical alveolar epithelial cells. Following inhaled administration of high dose LTI-03, a positive trend was observed in seven out of eight biomarkers, with evidence of reduced expression among profibrotic proteins produced by basal-like cells and fibroblasts that contribute to the progression of IPF, including data from four biomarkers that were statistically significant in the combined data set of Cohort 1 and Cohort 2, and data from five biomarkers that showed dose dependence relative to the data from those biomarkers in Cohort 1. Overall, the collective findings from this Phase 1b clinical trial provide the Company with strong confidence that LTI-03 has the potential to improve lung function and reverse the course of IPF. Twelve patients were enrolled in Cohort 2 of the ongoing Phase 1b clinical trial, three in the placebo arm and nine in the active arm. Patients had a bronchoscopy at baseline, received a high dose of LTI-03 twice a day for 14 days, followed by a bronchoscopy on day 14 and seven days of post-treatment follow-up. Cohort 2 findings include: educed expression of multiple profibrotic proteins active in both pathologic basal-like cells and fibroblasts, with four biomarkers showing statistically significant decreases in the combined data set supporting the potential of LTI-03 to reduce fibrosis, inflammation and associated functional changes in the lung. Dose dependent trends were observed in five biomarkers, including COL1A1, CXCL7, TSLP, GAL-7, and Surfactant protein D (SPD) which provide evidence of active LTI-03 pharmacodynamics. SPD, an indicator of epithelial cell health that is significantly linked to decline in lung function, decreased by 5% in Cohort 2 at 14 days of treatment, while current standard of care for IPF reduced SPD by 4% at 12-weeks in precedent trials. LTI-03 did not induce inflammation in peripheral blood mononuclear cells (PBMCs) in either Cohort, measured by pAKT, a safety marker for inflammation in this trial. LTI-03 was generally well-tolerated, and there were no drug-related adverse events that resulted in a discontinuation of the trial.

Init2winit2019 Posted - 2 weeks ago

$ALRN bring the volume .. this puppy ready to go.. lol

i_like_them_parabolic Posted - 10/31/24

$ALRN huge news!!

i_like_them_parabolic Posted - 10/31/24

$ALRN wowwww

Init2winit2019 Posted - 10/30/24

$ALRN that was a gift, thanks for that

taki Posted - 10/29/24

$ALRN should have bought. More. As usual. Selling the winner. Keeping the loser

PenkeTrading Posted - 10/28/24

I found you a MACD Bearish Reversal Divergence on the daily chart of Aileron Therapeutics Inc. $ALRN #Aileron #BearishReversalDivergence #NASDAQ

i_like_them_parabolic Posted - 10/28/24

$ALRN are there earnings today?

savage1 Posted - 10/23/24

$ALRN setup looks pretty good with some volume, minus the bad candle today. Any upcoming catalysts to push this over 3.80 to the breakout?

Init2winit2019 Posted - 10/23/24

$ALRN adding again.

gamgee11 Posted - 10/22/24

$ALRN $GNPX $PNBK $TCBP $TWG I don’t usually wake up for PM. Tomorrow is not the usual day

_www_larval_com_ Posted - 10/22/24

$PNBK 4%[34%] $ALRN -3%[2%] $TCBP -3%[9%] $GNPX -3%[144%] $TWG 3%[25%] most notable movement into the final minutes of trading.

rapture_iscoming Posted - 1 month ago

$DRUG taking all my profits from this (more than youve made in the past 5 years) and going over to $ALRN - I am expecting similar movement with that one tomorrow

RealJackBandit Posted - 1 month ago

$ALRN lfggg

themacromindset Posted - 1 month ago

$ALRN Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis

themacromindset Posted - 1 month ago

$ALRN shows bullish momentum, with notable players like Glaxo, Eli Lilly, and Novartis involved, along with previously positive news. For a quick play, watch these levels: Upside: $4.14, $4.92, $5.88 Downside: $3.24, $2.90 Please always do your dd

Stock_Titan Posted - 09/23/24

$ALRN Aileron Therapeutics Completes Enrollment in Cohort 2 of the Ongoing Phase 1b Clinical Trial Evaluating LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) https://www.stocktitan.net/news/ALRN/aileron-therapeutics-completes-enrollment-in-cohort-2-of-the-ongoing-wyl9wzdtyyq1.html

Fullratio Posted - 2 months ago

$ALRN debt is 100% smaller than its equity: https://fullratio.com/stocks/nasdaq-alrn/aileron-therapeutics

PenkeTrading Posted - 2 months ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Aileron Therapeutics Inc. Is that bullish or bearish? $ALRN #Aileron #RsiOverbought #NASDAQ

rapture_iscoming Posted - 2 months ago

$ALRN This is a start, I moved my sell order from $75 to $100

TheGunSlinger Posted - 2 months ago

$ALRN If this gets more volume and holds up on a higher time frame above 4 daily / weekly this thing can get moving fast.

TheGunSlinger Posted - 2 months ago

$ALRN The monthly time frame on the charts is looking good

ProfitGainer Posted - 2 months ago

$ALRN looking like something good has leaked out.

Init2winit2019 Posted - 2 months ago

$ALRN somebody wants in..

VrtcIl Posted - 2 months ago

$ALRN still gaining momentum towards 4$. The uptrend is supported by consistent greater highs and greater lows, with notable volume signaling increased buying interest. Price: 3.62 Float: 3.5M Short Float: 1.5 % 💰 Dollar Volume: 17.7K ℹ️ USA | Biotechnology